Aktiesnakken — November 2010
-
Pengehansen. Så ikke Rovsing. Hvad er op og ned i den?
-
Rovsing kom med lovende q1 i dag. Det bemærkede jeg her efter luk. Tror, som jeg har nævnt tidligere, at den er vendt og vil tage fart opad
-
måske endda jumpe op på emissionsniveau (fra sidste efterår)
-
dertil kan der komme flerårige ordrer (sm. bla. Siemens)
i forbindelse med signaludskiftning på diverse jernbaner. -
- en ekstra joker.
-
Journal of the American Society Nephrology (JASN). : New Urine Test Could Diagnose Acute Kidney Injury
http://www.newswise.com/articles/view/570487/?sc=rsla&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+NewswiseLatestNews+(Newswise%3A+Late -
Urinary Test Flags Acute Kidney Injury http://www.medpagetoday.com/Nephrology/GeneralNephrology/23313
-
Ny bio-markør banker NGAL : The biomarker appeared to be more specific for acute kidney injury than the gold-standard urinary marker neutrophil gelatinase-associated lipocalin (NGAL), they reported online in the Journal of the American Society of Nephrol
-
Journal of the American Society of Nephrology. http://www.medpagetoday.com/Nephrology/GeneralNephrology/23313
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind